The Sputnik V vaccine was found to be safe in a study. Credit: Diverse Stock Photos / Flickr (Creative Commons).

Understand the impact of the Ukraine conflict from a cross-sector perspective with the Global Data Executive Briefing: Ukraine Conflict

The World Health Organization (WHO) has delayed the analysis of Russia’s Sputnik V Covid-19 vaccine underway for emergency use amid the Ukraine crisis, Reuters reported.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

The news agency quoted WHO assistant-director general for Access to Medicines and Health Products Dr Mariângela Simão as saying in a press briefing that the inspections were supposed to be carried out in Russia on 7 March and were postponed for a later date.

She noted that the crisis in Ukraine had impacted assessments of the vaccine, adding that the health agency was experiencing various operational issues including snags in flight booking and using credit cards.

After Russia invaded Ukraine, western countries blocked their airspace to Russian aircraft and imposed tough financial and economic sanctions.

Simão further added: “This has been discussed with the Russian applicants and new dates will be set as soon as possible.”

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

WHO is analysing the vaccine for emergency use authorisation since last year. 

In October last year, the WHO put a hold on Sputnik V’s Emergency Use Listing (EUL) process citing pending missing data and legal procedures.

In a previously published study, the Sputnik V vaccine was found to be safe and could avert severe disease in infected individuals.

If WHO authorisation is granted, the vaccine could be procured as part of the COVAX for supply globally. 

Till date, the combination vector vaccine has obtained approvals in more than 70 countries across the globe. 

The vaccine manufacturing plans were halted due to the sanctions placed on Russia, Hindustan Times noted.

Apart from WHO, the vaccine is being analysed by the European Medicines Agency.